United States Biotechnology & Medical Research

Forty Seven Inc (FTSV)

Track

Ticker: FTSV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 1 Apr 2020
Value US$504,417.66 | Price 481.87 | Shares 26,603 (-46.5%)
Sale 1 Apr 2020
Value US$78,240.22 | Price 236.08 | Shares 71,447 (+32.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-04-03 2020-04-01 S Sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
26,603 -46.5%
481.87
US$504,418 		26,603 -46.5% 481.87 US$504,418
2020-04-03 2020-04-01 S Sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
71,447 +32.8%
236.08
US$78,240 		71,447 +32.8% 236.08 US$78,240
2020-04-03 2020-04-01 S Sale
1.4
RHOADS ANN D

Chief Financial Officer

Officer
62,912 +9.6%
114.56
US$3,005,622 		62,912 +9.6% 114.56 US$3,005,622
2020-04-03 2020-04-01 S Sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
79,195 -95.3%
95.42
US$7,556,787 		79,195 -95.3% 95.42 US$7,556,787
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
200 -0.0%
93.74
US$18,748 		200 -0.0% 93.74 US$18,748
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
42,095 -2.3%
93.29
US$3,926,878 		42,095 -2.3% 93.29 US$3,926,878
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,800 -0.6%
92.19
US$995,635 		10,800 -0.6% 92.19 US$995,635
2020-03-16 2020-03-11 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
196,905 -9.8%
94.72
US$18,650,212 		196,905 -9.8% 94.72 US$18,650,212
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
375 -0.0%
45.87
US$17,202 		375 -0.0% 45.87 US$17,202
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
11,420 -1.1%
45.17
US$515,795 		11,420 -1.1% 45.17 US$515,795
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
7,493 -0.7%
44.05
US$330,052 		7,493 -0.7% 44.05 US$330,052
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
5,712 -0.5%
43.15
US$246,466 		5,712 -0.5% 43.15 US$246,466
2020-01-16 2020-01-15 PlS Planned sale
Majeti Ravindra
1,011 -0.1%
36.78
US$37,187 		1,011 -0.1% 36.78 US$37,187
2020-01-16 2020-01-15 PlS Planned sale
Majeti Ravindra
23,989 -2.2%
36.33
US$871,511 		23,989 -2.2% 36.33 US$871,511
2019-12-30 2019-12-26 PlS Planned sale WEISSMAN IRVING Non-Executive Director
6,115 -0.3%
44.78
US$273,830 		6,115 -0.3% 44.78 US$273,830
2019-12-30 2019-12-26 PlS Planned sale WEISSMAN IRVING Non-Executive Director
23,885 -1.2%
44.08
US$1,052,851 		23,885 -1.2% 44.08 US$1,052,851
2019-12-17 2019-12-16 PlS Planned sale Majeti Ravindra Non-Executive Director
7,004 -0.6%
35.87
US$251,226 		7,004 -0.6% 35.87 US$251,226
2019-12-17 2019-12-16 PlS Planned sale Majeti Ravindra Non-Executive Director
17,996 -1.6%
35.34
US$635,943 		17,996 -1.6% 35.34 US$635,943
2019-12-11 2019-12-10 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
35.00
US$350,000 		10,000 -100.0% 35.00 US$350,000
2019-12-10 2019-12-09 PlS Planned sale WEISSMAN IRVING Non-Executive Director
10,180 -0.5%
17.25
US$175,646 		10,180 -0.5% 17.25 US$175,646
2019-12-10 2019-12-09 PlS Planned sale WEISSMAN IRVING Non-Executive Director
9,820 -0.5%
15.15
US$148,763 		9,820 -0.5% 15.15 US$148,763
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
22.00
US$440,000 		20,000 -1.7% 22.00 US$440,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
20.00
US$400,000 		20,000 -1.7% 20.00 US$400,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
18.00
US$360,000 		20,000 -1.7% 18.00 US$360,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
5,000 -0.4%
15.00
US$75,000 		5,000 -0.4% 15.00 US$75,000
2019-12-10 2019-12-09 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
30.00
US$300,000 		10,000 -100.0% 30.00 US$300,000
2019-11-22 2019-11-20 PlS Planned sale Majeti Ravindra Non-Executive Director
5,000 -0.4%
12.50
US$62,500 		5,000 -0.4% 12.50 US$62,500
2019-11-20 2019-11-18 PlS Planned sale
Majeti Ravindra
15,000 -1.2%
10.26
US$153,915 		15,000 -1.2% 10.26 US$153,915
2019-08-21 2019-08-16 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
663 -100.0%
6.36
US$4,216 		663 -100.0% 6.36 US$4,216
2019-07-24 2019-07-22 B Purchase
BIRD JEFFREY W
187,500 +3811.8%
8.00
US$1,500,000 		187,500 +3811.8% 8.00 US$1,500,000
2019-07-24 2019-07-22 B Purchase
BIRD JEFFREY W
562,500 +inf%
8.00
US$4,500,000 		562,500 +inf% 8.00 US$4,500,000
2019-07-24 2019-07-22 B Purchase
Lightspeed Venture Partners X, L.P.
Large shareholder
312,500 +17.5%
8.00
US$2,500,000 		312,500 +17.5% 8.00 US$2,500,000
2019-07-24 2019-07-22 B Purchase
Lightspeed Venture Partners X, L.P.
Large shareholder
312,500 +12.6%
8.00
US$2,500,000 		312,500 +12.6% 8.00 US$2,500,000
2019-06-27 2019-06-25 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
8,199 -11.9%
11.02
US$90,391 		8,199 -11.9% 11.02 US$90,391
2019-06-24 2019-06-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
8,301 -12.0%
11.04
US$91,626 		8,301 -12.0% 11.04 US$91,626
2019-05-22 2019-05-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
1,291 -2.1%
12.46
US$16,080 		1,291 -2.1% 12.46 US$16,080
2019-05-22 2019-05-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
15,209 -20.0%
12.07
US$183,646 		15,209 -20.0% 12.07 US$183,646
2019-05-17 2019-05-16 PlS Planned sale
Majeti Ravindra
2,088 -0.1%
16.02
US$33,460 		2,088 -0.1% 16.02 US$33,460
2019-05-17 2019-05-15 PlS Planned sale
Majeti Ravindra
2,223 -0.2%
16.01
US$35,584 		2,223 -0.2% 16.01 US$35,584
2019-05-07 2019-05-03 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
17.99
US$143,951 		8,000 -100.0% 17.99 US$143,951
2019-04-30 2019-04-26 PlS Planned sale
WEISSMAN IRVING
20,000 -1.0%
18.35
US$366,978 		20,000 -1.0% 18.35 US$366,978
2019-04-22 2019-04-18 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.12
US$299,054 		16,500 -21.4% 18.12 US$299,054
2019-04-17 2019-04-15 PlS Planned sale
Majeti Ravindra
25,000 -1.7%
18.30
US$457,505 		25,000 -1.7% 18.30 US$457,505
2019-04-05 2019-04-05 PlS Planned sale
WEISSMAN IRVING
6,518 -0.3%
17.15
US$111,799 		6,518 -0.3% 17.15 US$111,799
2019-04-08 2019-04-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.39
US$131,105 		8,000 -100.0% 16.39 US$131,105
2019-04-05 2019-04-03 PlS Planned sale
WEISSMAN IRVING
3,382 -0.2%
17.04
US$57,632 		3,382 -0.2% 17.04 US$57,632
2019-04-02 2019-03-29 PlS Planned sale
WEISSMAN IRVING
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2019-03-28 2019-03-26 PlS Planned sale
WEISSMAN IRVING
10,000 -0.5%
15.98
US$159,812 		10,000 -0.5% 15.98 US$159,812
2019-03-21 2019-03-19 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.15
US$299,401 		16,500 -21.4% 18.15 US$299,401
2019-03-19 2019-03-19 PlS Planned sale
Majeti Ravindra
5,292 -0.4%
18.03
US$95,398 		5,292 -0.4% 18.03 US$95,398
2019-03-19 2019-03-18 PlS Planned sale
Majeti Ravindra
9,708 -0.7%
18.02
US$174,938 		9,708 -0.7% 18.02 US$174,938
2019-03-19 2019-03-15 PlS Planned sale
Majeti Ravindra
20,000 -1.3%
17.68
US$353,616 		20,000 -1.3% 17.68 US$353,616
2019-03-06 2019-03-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.94
US$135,550 		8,000 -100.0% 16.94 US$135,550
2019-03-05 2019-03-01 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
3,616 -0.2%
17.04
US$61,603 		3,616 -0.2% 17.04 US$61,603
2019-02-27 2019-02-27 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
4,280 -0.2%
17.01
US$72,805 		4,280 -0.2% 17.01 US$72,805
2019-02-27 2019-02-26 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
12,104 -0.6%
16.93
US$204,973 		12,104 -0.6% 16.93 US$204,973
2019-02-27 2019-02-25 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
17.03
US$170,325 		10,000 -0.5% 17.03 US$170,325
2019-02-26 2019-02-25 PlS Planned sale
Majeti Ravindra
Non-Executive Director
10,266 -0.7%
16.07
US$164,990 		10,266 -0.7% 16.07 US$164,990
2019-02-26 2019-02-22 PlS Planned sale
Majeti Ravindra
Non-Executive Director
22,371 -1.5%
16.01
US$358,131 		22,371 -1.5% 16.01 US$358,131
2019-02-21 2019-02-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
9,410 -13.4%
14.94
US$140,546 		9,410 -13.4% 14.94 US$140,546
2019-02-21 2019-02-19 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
2,500 -100.0%
15.05
US$37,621 		2,500 -100.0% 15.05 US$37,621
2019-02-21 2019-02-19 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
7,090 -10.5%
15.06
US$106,797 		7,090 -10.5% 15.06 US$106,797
2019-02-05 2019-02-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
14.86
US$118,874 		8,000 -100.0% 14.86 US$118,874
2019-02-05 2019-02-04 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
6,445 -0.3%
15.02
US$96,805 		6,445 -0.3% 15.02 US$96,805
2019-02-05 2019-02-01 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
3,219 -0.2%
15.02
US$48,362 		3,219 -0.2% 15.02 US$48,362
2019-02-01 2019-01-31 PlS Planned sale
Majeti Ravindra
Non-Executive Director
3,834 -0.3%
14.57
US$55,872 		3,834 -0.3% 14.57 US$55,872
2019-02-01 2019-01-30 PlS Planned sale
Majeti Ravindra
Non-Executive Director
16,166 -1.1%
14.46
US$233,683 		16,166 -1.1% 14.46 US$233,683
2019-01-30 2019-01-28 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
336 -0.0%
15.00
US$5,041 		336 -0.0% 15.00 US$5,041
2019-01-23 2019-01-18 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
20,000 -68.9%
14.59
US$291,892 		20,000 -68.9% 14.59 US$291,892
2019-01-17 2019-01-16 PlS Planned sale
Majeti Ravindra
Non-Executive Director
4,363 -0.3%
16.00
US$69,822 		4,363 -0.3% 16.00 US$69,822
2019-01-17 2019-01-15 PlS Planned sale
Majeti Ravindra
Non-Executive Director
23,000 -1.5%
15.73
US$361,808 		23,000 -1.5% 15.73 US$361,808
2019-01-11 2019-01-09 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
17.05
US$170,490 		10,000 -0.5% 17.05 US$170,490
2019-01-08 2019-01-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
15.55
US$124,362 		8,000 -100.0% 15.55 US$124,362
2019-01-11 2018-12-26 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
15.77
US$157,685 		10,000 -0.5% 15.77 US$157,685
2018-12-28 2018-12-26 PlS Planned sale McCamish Mark Anthony

President and CEO

Executive Director
2,968 -24.7%
15.89
US$47,160 		2,968 -24.7% 15.89 US$47,160
Explore more

More insider trading research around Forty Seven Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America